IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid, data-driven breakthroughs. This hybrid approach is cutting costs, ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company focused on the development of innovative therapies, announces the signing of a binding ...

Fortrea forecasts revenue and EBITDA declines for 2025. With a $477.16M market cap, financial improvement could drive stock price growth.

Four medical affairs leaders reveal what’s working (and what’s not) when it comes to engaging time-starved HCPs in 2025.

Q1 2025 Earnings Call Transcript May 8, 2025 Operator: Good afternoon, and welcome to OmniAb, Inc. First quarter 2025 financial results and business update conference call. At this time, all ...

Government funding in nanotechnology research and favorable R&D incentives is fast-tracking market growth across developed economies. INDORE, INDIA, May 21, 2025 /EINPresswire.com/ -- Nanomaterials ...

Q4 2025 Earnings Call Transcript May 15, 2025 Doximity, Inc. beats earnings expectations. Reported EPS is $0.38, expectations ...

Discover the top 3 undervalued Diversified Consumer Services stocks for Thursday, May 15 based on AAII’s Stock Grades.

Three households on the same street grapple with aging in their homes — reflecting some common conundrums aging Americans ...

Tempus AI, Inc. TEM is scheduled to report first-quarter fiscal 2025 results on May 6.